Terms: = Brain cancer AND B2M, P61769, 567, ENSG00000166710 AND Treatment
22 results:
1. Molecular Features of Resected Melanoma brain Metastases, Clinical Outcomes, and Responses to Immunotherapy.
Vasudevan HN; Delley C; Chen WC; Mirchia K; Pan S; Shukla P; Aabedi AA; Nguyen MP; Morshed RA; Young JS; Boreta L; Fogh SE; Nakamura JL; Theodosopoulos PV; Phillips J; Hervey-Jumper SL; Daras M; Pike L; Aghi MK; Tsai K; Raleigh DR; Braunstein SE; Abate AR
JAMA Netw Open; 2023 Aug; 6(8):e2329186. PubMed ID: 37589977
[TBL] [Abstract] [Full Text] [Related]
2. Vorinostat-induced acetylation of RUNX3 reshapes transcriptional profile through long-range enhancer-promoter interactions in natural killer cells.
Lee EC; Kim K; Jung WJ; Kim HP
BMB Rep; 2023 Jul; 56(7):398-403. PubMed ID: 37220907
[TBL] [Abstract] [Full Text] [Related]
3. Management of Patients with Spine Tumors Strengthened by a Dedicated Multidisciplinary Spine Tumor Board: A 15-Year Single-Institutional Experience.
Mann M; Annable N; Emch TM; Wu J; Chao ST; Benzel E; Winkelman R; Angelov L
World Neurosurg; 2023 Jul; 175():e397-e405. PubMed ID: 37011761
[TBL] [Abstract] [Full Text] [Related]
4. Pooled Analysis of Meningioma Risk Following treatment for Childhood cancer.
Withrow DR; Anderson H; Armstrong GT; Hawkins M; Journy N; Neglia JP; de Vathaire F; Tucker MA; Inskip PD; Brenner AV; Stovall MA; Diallo I; Berrington de Gonzalez A; Veiga LHS
JAMA Oncol; 2022 Dec; 8(12):1756-1764. PubMed ID: 36201196
[TBL] [Abstract] [Full Text] [Related]
5. SGEResU-Net for brain tumor segmentation.
Liu D; Sheng N; He T; Wang W; Zhang J; Zhang J
Math Biosci Eng; 2022 Mar; 19(6):5576-5590. PubMed ID: 35603369
[TBL] [Abstract] [Full Text] [Related]
6. Retrospective Chart Review of Dabrafenib Plus Trametinib in Patients with Metastatic BRAF V600-Mutant Melanoma Treated in the Individual Patient Program (DESCRIBE Italy).
Aglietta M; Chiarion-Sileni V; Fava P; Guidoboni M; Depenni R; Minisini A; Consoli F; Ascierto P; Rinaldi G; Banzi M; Marconcini R; Gueli R; Ferraresi V; Tucci M; Tonini G; Lo Re G; Guida M; Del Vecchio M; Marcon IG; Queirolo P
Target Oncol; 2021 Nov; 16(6):789-799. PubMed ID: 34755244
[TBL] [Abstract] [Full Text] [Related]
7. Metformin and Risk of Malignant brain Tumors in Patients with Type 2 Diabetes Mellitus.
Tseng CH
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439890
[TBL] [Abstract] [Full Text] [Related]
8. b2m overexpression correlates with malignancy and immune signatures in human gliomas.
Zhang H; Cui B; Zhou Y; Wang X; Wu W; Wang Z; Dai Z; Cheng Q; Yang K
Sci Rep; 2021 Mar; 11(1):5045. PubMed ID: 33658560
[TBL] [Abstract] [Full Text] [Related]
9. CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma.
Choi BD; Yu X; Castano AP; Darr H; Henderson DB; Bouffard AA; Larson RC; Scarfò I; Bailey SR; Gerhard GM; Frigault MJ; Leick MB; Schmidts A; Sagert JG; Curry WT; Carter BS; Maus MV
J Immunother Cancer; 2019 Nov; 7(1):304. PubMed ID: 31727131
[TBL] [Abstract] [Full Text] [Related]
10. M1b Disease in the 8th Edition of TNM Staging of Lung cancer: Pattern of Single Extrathoracic Metastasis and Clinical Outcome.
Park H; Dahlberg SE; Lydon CA; Araki T; Hatabu H; Rabin MS; Johnson BE; Nishino M
Oncologist; 2019 Aug; 24(8):e749-e754. PubMed ID: 30696724
[TBL] [Abstract] [Full Text] [Related]
11. Outcome After Radiation Therapy for Langerhans Cell Histiocytosis Is Dependent on Site of Involvement.
Laird J; Ma J; Chau K; Chelius M; Shi W; Zhang Z; Lok BH; Yahalom J
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):670-678. PubMed ID: 29413280
[TBL] [Abstract] [Full Text] [Related]
12. Perfusion imaging of brain gliomas using arterial spin labeling: correlation with histopathological vascular density in MRI-guided biopsies.
Ningning D; Haopeng P; Xuefei D; Wenna C; Yan R; Jingsong W; Chengjun Y; Zhenwei Y; Xiaoyuan F
Neuroradiology; 2017 Jan; 59(1):51-59. PubMed ID: 27924360
[TBL] [Abstract] [Full Text] [Related]
13. Craniopharyngioma: long-term consequences of a chronic disease.
Müller HL
Expert Rev Neurother; 2015; 15(11):1241-4. PubMed ID: 26523617
[TBL] [Abstract] [Full Text] [Related]
14. Photodynamic therapy in the treatment of brain tumours. A feasibility study.
Vanaclocha V; Sureda M; Azinovic I; Rebollo J; Cañón R; Sapena NS; Cases FG; Brugarolas A
Photodiagnosis Photodyn Ther; 2015 Sep; 12(3):422-7. PubMed ID: 26073912
[TBL] [Abstract] [Full Text] [Related]
15. Expression stability of reference genes for quantitative RT-PCR of healthy and diseased pituitary tissue samples varies between humans, mice, and dogs.
van Rijn SJ; Riemers FM; van den Heuvel D; Wolfswinkel J; Hofland L; Meij BP; Penning LC
Mol Neurobiol; 2014 Apr; 49(2):893-9. PubMed ID: 24135907
[TBL] [Abstract] [Full Text] [Related]
16. Gliomatosis cerebri: 20 years of experience at the Children's Hospital of Philadelphia.
Armstrong GT; Phillips PC; Rorke-Adams LB; Judkins AR; Localio AR; Fisher MJ
Cancer; 2006 Oct; 107(7):1597-606. PubMed ID: 16955507
[TBL] [Abstract] [Full Text] [Related]
17. Efficacy and safety of 48 weeks of treatment with octreotide LAR in newly diagnosed acromegalic patients with macroadenomas: an open-label, multicenter, non-comparative study.
Grottoli S; Celleno R; Gasco V; Pivonello R; Caramella D; Barreca A; Ragazzoni F; Pigliaru F; Alberti D; Ferrara R; Angeletti G
J Endocrinol Invest; 2005 Dec; 28(11):978-83. PubMed ID: 16483175
[TBL] [Abstract] [Full Text] [Related]
18. Predicting therapeutic response and degree of pituitary tumour shrinkage during treatment of acromegaly with octreotide LAR.
Jenkins PJ; Emery M; Howling SJ; Evanson J; Besser GM; Monson JP
Horm Res; 2004; 62(5):227-32. PubMed ID: 15477693
[TBL] [Abstract] [Full Text] [Related]
19. Spot-scanning proton radiation therapy for recurrent, residual or untreated intracranial meningiomas.
Weber DC; Lomax AJ; Rutz HP; Stadelmann O; Egger E; Timmermann B; Pedroni ES; Verwey J; Miralbell R; Goitein G;
Radiother Oncol; 2004 Jun; 71(3):251-8. PubMed ID: 15172139
[TBL] [Abstract] [Full Text] [Related]
20. Combination therapy with irinotecan and protein kinase C inhibitors in malignant glioma.
Chen TC; Su S; Fry D; Liebes L
Cancer; 2003 May; 97(9 Suppl):2363-73. PubMed ID: 12712458
[TBL] [Abstract] [Full Text] [Related]
[Next]
